| Urothelial Carcinoma In Situ studied in …STUDIED_INderived12 of 12show fewer |
|---|
| → studied in | NCT07189793Phase 2 · not yet recruiting Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study · condition mapped ALIAS · 12 trials mapped (5 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04164082Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (5 active) | — | — | Bladder Flat Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07725796Phase 1 · not yet recruiting A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC · condition mapped ONTOLOGY_EXACT · 12 trials mapped (5 active) | — | — | Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07231809NA · not yet recruiting Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients · condition mapped ALIAS · 12 trials mapped (5 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05375903Phase 1 · completed A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) · condition mapped ALIAS · 12 trials mapped (5 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04496219Phase 2 · completed Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (5 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06167356recruiting Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. · condition mapped ONTOLOGY_EXACT · 12 trials mapped (5 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02901548Phase 2 · terminated Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder · condition mapped ALIAS · 12 trials mapped (5 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04770974unknown Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic · condition mapped ONTOLOGY_EXACT · 12 trials mapped (5 active) | — | — | Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04647981completed Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test. · condition mapped ONTOLOGY_EXACT · 12 trials mapped (5 active) | — | — | Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03335059Phase 3 · terminated Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. · condition mapped ALIAS · 12 trials mapped (5 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01304173completed Retrospective Chart Review of Valstar · condition mapped ALIAS · 12 trials mapped (5 active) | — | — | Bladder Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |